Last data update: Nov 17, 2023. (Total: 4477 publications since 2011)
- Page last reviewed:Oct 1, 2023
- Page last updated:Nov 17, 2023
- Content source:
|Query Trace: Gurbaxani B[original query]|
| COVID-19 Scientific Publications From the Centers for Disease Control and Prevention, January 2020-January 2022.
Meites E , Knuth M , Hall K , Dawson P , Wang TW , Wright M , Yu W , Senesie S , Stephenson E , Imachukwu C , Sayi T , Gurbaxani B , Svendsen ER , Khoury MJ , Ellis B , King BA .
Public Health Rep 2022 138 (2) 333549221134130
| Quantifying the risk of undetected HIV, hepatitis B virus, or hepatitis C virus infection in Public Health Service increased risk donors.
Jones JM , Gurbaxani BM , Asher A , Sansom S , Annambhotla P , Moorman AC , Brooks JT , Basavaraju SV .
Am J Transplant 2019 19 (9) 2583-2593
| A model to estimate the probability of human immunodeficiency virus and hepatitis C infection despite negative nucleic acid testing among increased-risk organ donors.
Annambhotla Pallavi D, Gurbaxani Brian M, Kuehnert Matthew J, Basavaraju Sridhar V. Transplant infectious disease : an official journal of the Transplantation Society 2017 Apr 19(2) .
Transplant infectious disease : an official journal of the Transplantation Society 2017 Apr 19(2)
| Functional genomics of serotonin receptor 2A (HTR2A): interaction of polymorphism, methylation, expression and disease association.
Falkenberg Virginia R, Gurbaxani Brian M, Unger Elizabeth R, Rajeevan Mangalathu S. Neuromolecular medicine 2011 Mar 13(1) 66-76 .
Neuromolecular medicine 2011 Mar 13(1) 66-76